<SEC-DOCUMENT>0001104659-16-162852-index.html : 20161220 <SEC-HEADER>0001104659-16-162852.hdr.sgml : 20161220 <ACCEPTANCE-DATETIME>20161219173537 ACCESSION NUMBER: 0001104659-16-162852 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20161219 FILED AS OF DATE: 20161220 DATE AS OF CHANGE: 20161219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 162059798 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>a16-23188_26k.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: a16-23188_26k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>2 <FILENAME>a16-23188_2ex3d1.htm <DESCRIPTION>EX-3.1 <TEXT> Document 2 - file: a16-23188_2ex3d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a16-23188_2ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a16-23188_2ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>a16-23188_2ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: a16-23188_2ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g231882kki001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g231882kki001.jpg
</DOCUMENT> </SEC-DOCUMENT>